stocktools
Offerings // Galmed Pharmaceuticals Ltd.

GLMD offering history

Every offering-related filing in Galmed Pharmaceuticals Ltd.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 370 filings back to Dec 31, 2013.

Last executed offering
Jul 18, 2023
424B4 — priced deal (shares or notes)
Last registration (announced)
Aug 18, 2025
F-1 — capacity, not a sale
Executed, last 12 months
0
424B pricings + 8-K 3.02 sales
Registered, last 12 months
1
S-1/S-3/F-series registrations
DateFilingWhat it means
Jun 22, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jun 8, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Apr 1, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 2, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Sep 2, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Aug 21, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Aug 21, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Aug 18, 2025F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Apr 8, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Nov 21, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Nov 14, 2024F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Oct 28, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Oct 28, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Oct 21, 2024F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Sep 9, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Sep 9, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Aug 30, 2024F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Nov 29, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 18, 2023424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Jul 14, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 13, 2023F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Jul 12, 2023F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Jun 28, 2023F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Jun 28, 2023FWP →MARKETINGFree-writing prospectus — offering being marketed
Jun 16, 2023F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Jul 1, 2022424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 1, 2021EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 26, 2021F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Feb 18, 2021424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 16, 2021424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 15, 2020424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 21, 2018424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 18, 2018424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 18, 2018FWP →MARKETINGFree-writing prospectus — offering being marketed
Apr 4, 2018424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 2, 2018EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 26, 2018F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Dec 22, 2017424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 7, 2017424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jun 1, 2016424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
GLMD offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full GLMD workspace →
GLMD offering FAQ

When did GLMD last execute an offering?

Per SEC filings, Galmed Pharmaceuticals Ltd.'s most recent priced offering document is a 424B4 filed 2023-07-18. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did GLMD last announce or register an offering?

The most recent registration is a F-1 filed 2025-08-18. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.